1. Home
  2. AGNCM vs INM Comparison

AGNCM vs INM Comparison

Compare AGNCM & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNCM

AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

HOLD

Current Price

$25.15

Market Cap

0.0

Sector

Real Estate

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.11

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGNCM
INM
Founded
2008
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
3.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGNCM
INM
Price
$25.15
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.8K
150.0K
Earning Date
01-26-2026
02-11-2026
Dividend Yield
8.85%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$956,000,000.00
$4,798,116.00
Revenue This Year
$8.02
N/A
Revenue Next Year
$65.46
N/A
P/E Ratio
$16.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.01
$1.12
52 Week High
$25.60
$8.27

Technical Indicators

Market Signals
Indicator
AGNCM
INM
Relative Strength Index (RSI) 65.36 35.98
Support Level $24.94 $1.18
Resistance Level $25.09 $1.35
Average True Range (ATR) 0.14 0.10
MACD 0.03 0.00
Stochastic Oscillator 77.11 4.74

Price Performance

Historical Comparison
AGNCM
INM

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: